Arbutus Biopharma Corp. (ABUS)
4.16
0.00 (0.00%)
USD |
NASDAQ |
Feb 11, 16:00
4.18
+0.02
(+0.48%)
Pre-Market: 09:12
Arbutus Biopharma EPS Diluted (Quarterly) : -0.0404 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -0.5128 |
| Merck & Co., Inc. | 1.191 |
| Trevi Therapeutics, Inc. | -0.0813 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.742M |
| Revenue (Quarterly) | 0.529M |
| Total Expenses (Quarterly) | 8.271M |
| Enterprise Value | 710.97M |
| Gross Profit Margin (Quarterly) | 97.92% |
| Profit Margin (Quarterly) | -1.46K% |
| Earnings Yield | -5.33% |
| Normalized Earnings Yield | -3.969 |